According to Arrowhead Pharmaceuticals 's latest financial reports the company's total debt is C$0.75 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-09-30 | C$0.68 B | 340.63% |
2023-09-30 | C$0.15 B | 40.32% |
2022-09-30 | C$0.11 B | 242.4% |
2021-09-30 | C$32.57 M | 15.16% |
2020-09-30 | C$28.29 M | |
2019-09-30 | N/A | -100% |
2018-09-30 | C$3 M | -4.44% |
2017-09-30 | C$3.14 M | -12.4% |
2016-09-30 | C$3.58 M | 252.56% |
2015-09-30 | C$1.01 M | -10.8% |
2014-09-30 | C$1.14 M | -51.98% |
2013-09-30 | C$2.37 M | -0.83% |
2012-09-30 | C$2.39 M | 280.63% |
2011-09-30 | C$0.62 M | 22% |
2010-09-30 | C$0.51 M | -60.63% |
2009-09-30 | C$1.31 M | -19.81% |
2008-09-30 | C$1.63 M | |
2002-09-30 | C$0.99 M | 13.26% |
2001-09-30 | C$0.88 M | 4.2% |
2000-09-30 | C$0.84 M | 2.01% |
1999-09-30 | C$0.83 M | -49.14% |
1998-09-30 | C$1.63 M | 15.36% |
1997-09-30 | C$1.41 M |